PIMOBENDAN powder
Country: United States
Language: English
Source: NLM (National Library of Medicine)
Summary of Product characteristics
(SPC)
25-10-2021
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
PIMOBENDAN (UNII: 34AP3BBP9T) (PIMOBENDAN - UNII:34AP3BBP9T)
Available from:
Medisca Inc.
Administration route:
NOT APPLICABLE
Authorization status:
Bulk Ingredient For Animal Drug Compounding
Summary of Product characteristics
PIMOBENDAN- PIMOBENDAN POWDER
MEDISCA INC.
----------
PIMOBENDAN
PIMOBENDAN, EP
DESCRIPTION: White or slightly yellowish powder, hygroscopic.
NDC 38779-2641-4
Packed by Medisca Inc.
Plattsburgh, NY, 12901, USA
MEDISCA
TO ORDER CALL 1 (800) 932-1039
PIMOBENDAN, EP
Caution: Not For Human Use
25 g
For use and distribution in prescription compounding, manufacturing,
processing or
repacking only in accordance with FDA regulations and applicable law.
STORAGE: Preserve in airtight containers.
Lot:
Exp:
Cas: 74150-27-9
See Material Safety Data Sheet
PIMOBENDAN
pimobendan powder
PRODUCT INFORMATION
PRODUCT TYPE
BULK INGREDIENT
ITEM CODE (SOURCE)
NDC:38779-2641
Medisca Inc.
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRENGTH
PIMOBENDAN (UNII: 34AP3BBP9T) (PIMOBENDAN - UNII:34AP3BBP9T)
PIMOBENDAN
1 g in 1 g
PACKAGING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1 NDC:38779-2641-3
5 g in 1 BOTTLE, GLASS
01/08/2013
2 NDC:38779-2641-4
25 g in 1 JAR
01/08/2013
MARKETING INFORMATION
MARKETING CATEGORY
APPLICATION NUMBER OR
MONOGRAPH CITATION
MARKETING
START DATE
MARKETING END
DATE
BULK INGREDIENT FOR ANIMAL DRUG
COMPOUNDING
01/08/2013
LABELER -
Medisca Inc. (794301960)
Revised: 10/2021
Read the complete document
